Products

Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/ Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3

China Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3, Find details about China Phenytoin Sodium, 630-93-3 from Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3

Model NO.
Phenytoin sodium
Mf
C15h13n2nao2
MW
276.27
CAS
630-93-3
Appearance
White Crystalline Powder
Function
Biological and Pharmaceutical Intermediates
Shelf Life
2 Years
Test Method
HPLC UV
Storage
Cool Dry Place
Payment
Tt.Western Union .Credit Card.Moneygram
Delivery Time
Within 2 Days
Certificate
COA MSDS
Sample
Available
Trademark
Faithful
Transport Package
Aluminum Foil Bag Packaging
Specification
10g/bag; 100g/bag; 1kg/bag
Origin
China
Model NO.
Phenytoin sodium
Mf
C15h13n2nao2
MW
276.27
CAS
630-93-3
Appearance
White Crystalline Powder
Function
Biological and Pharmaceutical Intermediates
Shelf Life
2 Years
Test Method
HPLC UV
Storage
Cool Dry Place
Payment
Tt.Western Union .Credit Card.Moneygram
Delivery Time
Within 2 Days
Certificate
COA MSDS
Sample
Available
Trademark
Faithful
Transport Package
Aluminum Foil Bag Packaging
Specification
10g/bag; 100g/bag; 1kg/bag
Origin
China
Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3Zafirlukast 107753-78-6/Pramlintide acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin sodium 630-93-3

Introduction

Phenytoin sodium Chemical Properties
solubility aqueous base: soluble
form Crystalline Powder
color White to almost white
Merck 14,7322
InChIKeyFJPYVLNWWICYDW-UHFFFAOYSA-M
EPA Substance Registry SystemDiphenylhydantoin sodium (630-93-3)

Function
Mainly for the treatment of complex partial seizures (temporal lobe epilepsy, psychomotor seizures), simple partial seizures (limited episodes), generalized tonic-clonic seizures and status epilepticus.
Application
Used in pharmaceutical raw materials and scientific research.
Specification

ItemStandardTest Results

Identification

A.H-NMR:Comply with the structure

Complies

B.LC-MS:Comply with the structure

Complies

C.The IR spectrum of sample should be identical with that of reference standard;

Complies

D.HPLC-ESI-MS

The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.

Complies

Loss on drying

≤0.5%

0.11%

Heavy metals

≤10 ppm

<10ppm

Sulphated ash

≤0.2%, determined on 1.0 g.

0.009%

Related substances

Unspecified impurities: for each impurity

≤0.10%

<0.10%

Total Impurity

≤1.0%

0.18%

Purity

≥99.0%

99%

Assay

99.0%~101.0% (anhydrous substance).

99%

Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3Zafirlukast 107753-78-6/Pramlintide Acetate 196078-30-5/Analgin 5907-38-0/Alendronate Sodium 121268-17-5/Phenytoin 57-41-0/ Phenytoin Sodium 630-93-3

You Might Also Like